Antonia Blackwell

Years Active: 2023-2023
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Jessica L Chitty, Michelle Yam, Lara Perryman, Amelia L Parker, Joanna N Skhinas, Yordanos F I Setargew, Ellie T Y Mok, Emmi Tran, Rhiannon D Grant, Sharissa L Latham, Brooke A Pereira, Shona C Ritchie, Kendelle J Murphy, Michael Trpceski, Alison D Findlay, Pauline Melenec, Elysse C Filipe, Audrey Nadalini, Sipiththa Velayuthar, Gretel S Major, Kaitlin Wyllie, Michael Papanicolaou, Shivanjali Ratnaseelan, Phoebe A Phillips, George Sharbeen, Janet Youkhana, Alice Russo, Antonia Blackwell, Jordan F Hastings, Morghan C Lucas, Cecilia R Chambers, Daniel A Reed, Janett Stoehr, Claire Vennin, Ruth Pidsley, Anaiis Zaratzian, Andrew M Da Silva, Michael Tayao, Brett Charlton, David Herrmann, Max Nobis, Susan J Clark, Andrew V Biankin, Amber L Johns, David R Croucher, Adnan Nagrial, Anthony J Gill, Sean M Grimmond, null null, null null, Marina Pajic, Paul Timpson, Wolfgang Jarolimek, Thomas R Cox
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Nature cancer (2023)

Antonia Blackwell.css-eqlu8i{font-size:small;padding-left:4px;}